News und Analysen
Why Advance Auto Parts Stock Keeps Dropping
Shares of Advance Auto Parts (NYSE: AAP) retreated for a second straight day Friday after reporting earnings on Wednesday. The news this week wasn't great. Revenues inched up less than 1%
Why Premier Stock Fell 16% This Week
Shares of Premier (NASDAQ: PINC) are down 15.5% this week as of 12:05 p.m. ET Friday, according to data provided by S&P Global Market Intelligence, after the healthcare-improvement leader announced
Is Regeneron Stock a Buy Now?
There's a lot going on with biotech giant Regeneron (NASDAQ: REGN) that may be of interest to investors. The company could soon face biosimilar competition from one of its key growth drivers, Eylea
Is Medtronic Stock a Buy Now?
Companies that can withstand market volatility make for good long-term investments. Ireland-based Medtronic (NYSE: MDT), a major player in the medical device industry, has repeatedly demonstrated
3 Growth Stocks That Can Soar 50%, According to Wall Street
Analysts' price targets can help investors get an idea of whether there's a lot of bullishness surrounding a stock. But in some cases, a high upside can simply be due to elevated price targets that
Stock Market Sell-Off: 3 Tech Stocks Investors Should Avoid Right Now
The stock market seems uncertain right now. Some stocks experienced continued declines even after a massive sell-off in the 2022 bear market. Others recovered significantly in the first half of the
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc
1 Green Flag for AT&T Stock Investors
Fool.com contributor Parkev Tatevosian highlights AT&T's (NYSE: T) financial progress in reducing its debt to lower interest expenses.
*Stock prices used were the afternoon prices of Aug. 22, 2023
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris
If you're looking for a high-yield dividend stock in the healthcare sector, you might be interested in comparing Takeda Pharmaceutical (NYSE: TAK) and Viatris (NASDAQ: VTRS).
Both companies offer
Why Medtronic Stock Dropped Today
Shares of Medtronic (NYSE: MDT) fell 3.1% on Thursday, according to data provided by S&P Global Market Intelligence, giving back yesterday's post-earnings gains after it announced advisors to the
Why Invitae Stock Is Crashing Today
Shares of Invitae (NYSE: NVTA) were crashing 19.4% lower as of 12:13 p.m. ET on Thursday. The decline came on the heels of two developments.
Invitae revealed in a regulatory filing on Wednesday that
3 Dividend Stocks to Buy and Hold Until You Retire
Retirement is a big problem for many Americans. According to a recent poll from BlackRock, just 56% of people believe that they will be able to retire comfortably and have the life they want in
2 No-Brainer Biotech Stocks to Buy Right Now
Following the market's gloomy 2022, this year has been a breath of fresh air with the S&P 500 rising 14% so far in 2023. Some biotech stocks have soared even higher thanks to strong products. Cystic
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
Novo Nordisk's (NYSE: NVO) molecule semaglutide is the active ingredient in its smash-hit therapies for weight loss and diabetes, which you've probably heard of under the trade names Wegovy and
Is Sage Therapeutics Stock in Trouble After Dropping 50% in a Month?
News from the Food and Drug Administration (FDA) can often make or break a stock. This month, it broke Sage Therapeutics (NASDAQ: SAGE).
Although the company obtained approval for its depression
AT&T Is Generating Growth in a Stagnant Industry
Fool.com contributor Parkev Tatevosian discusses how AT&T (NYSE: T) is managing to add customers and revenue despite operating in a saturated market.
*Stock prices used were the afternoon prices of
2 Ultra-Cheap High-Yield Dividend Stocks to Buy Now
Dividend stocks can be a port in the storm. Thanks to powerful wealth-building vehicles like dividend reinvestment plans, these stocks can take advantage of the power of both dollar-cost averaging
Is Sarepta Therapeutics Stock a Top Growth Vehicle?
Growth stocks have hit a rough patch lately. The Nasdaq Composite, a benchmark for many growth-oriented companies, has declined by about 5% since the beginning of August, and many individual growth
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
If Wall Street is having a back-to-school sale, Cathie Wood is shopping. The widely followed growth investor who leads Ark Invest did a fair amount of buying on Tuesday. She publishes her daily
Could This Medicine Be the Next Winner for Novartis?
Earlier this month, the Switzerland-based pharmaceutical Novartis (NYSE: NVS) shared encouraging news from two phase 3 clinical trials of its drug candidate remibrutinib for a skin condition known
3 Stocks With High Dividend Yields
Many companies have put a lower priority on paying dividends over the years. The average dividend yield of stocks in the S&P 500 has fallen from over 3% a few decades ago to less than 2% in the past
Want Growing Passive Income? This Dividend King Could Be a Smart Buy
More than three years after deeming COVID-19 a global health emergency, the World Health Organization ended the pandemic's special status in May.
This was certainly welcome news for numerous
These 2 Stocks Could Skyrocket by 54% and 119%, According to Wall Street
Unprofitable clinical-stage biotechs have lost their appeal in the past year, given the challenging economic and market conditions we still haven't entirely left behind. That's why companies such as
3 Biotechs Compete for the Same $108-Billion-Dollar Market. Are They a Buy?
By some estimates, the market for nonalcoholic steatohepatitis (NASH) medicines will be worth a startling $108 billion by 2030, even though no drugs are yet on the market for it. That makes it a